Journal
CURRENT CARDIOLOGY REPORTS
Volume 21, Issue 12, Pages -Publisher
SPRINGER
DOI: 10.1007/s11886-019-1238-1
Keywords
Cardiac sarcoidosis; Cardiac magnetic resonance; Positron emission tomography; Implantable cardioverter defibrillator; Sudden cardiac death
Categories
Funding
- NCATS NIH HHS [UL1 TR002649] Funding Source: Medline
Ask authors/readers for more resources
Purpose of ReviewIn this state-of-the-art review, we highlight our current understanding of diagnosis, assessment, and management of cardiac sarcoidosis (CS), focusing on recently published data and expert consensus statement guidelines.Recent FindingsAcademic interest in cardiac sarcoidosis research has increased over the past decade along with increased clinical awareness among clinicians. In 2014, the Heart Rhythm Society published the first expert consensus statement on diagnosing and managing arrhythmias associated with CS. Cardiac magnetic resonance has emerged as a valuable tool both for diagnosing CS and predicting risk of life-threatening ventricular arrhythmias based on burden of late gadolinium enhancement. Cardiac fluorodeoxyglucose-positron emission tomography now plays a role in diagnosis, risk stratification, and assessing response to immunosuppressive therapy.SummaryCollaborative, multidisciplinary research efforts are needed to further our understanding of this rare, complex disease. Two large multicenter prospective registries-the international Cardiac Sarcoidosis Consortium and the Canadian Cardiac Sarcoidosis Research Group-are enrolling patients to help provide insights into the natural history of the disease and current treatment strategies. Future research should focus on randomized controlled trials comparing different treatment strategies and identifying and testing novel therapeutic agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available